Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
60,620.02 -1,139.94 (-1.85%) CMC Crypto 200
1,264.48 -19.35 (-1.51%)
INVA Dec 2024 15.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:20AM EDT. Market open.
| Previous close | 2.5500 |
| Open | 1.9500 |
| Bid | 1.4000 |
| Ask | 3.5000 |
| Strike | 15.00 |
| Expiry date | 2024-12-20 |
| Day's range | 1.9500 - 2.5500 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
Simply Wall St.Calculating The Fair Value Of Innoviva, Inc. (NASDAQ:INVA)
Key Insights Innoviva's estimated fair value is US$19.59 based on 2 Stage Free Cash Flow to Equity Current share price...
Business WireInnoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
BURLINGAME, Calif., June 03, 2024--Innoviva, Inc. (Nasdaq: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL
- GuruFocus.com
Innoviva Inc (INVA) Reports First Quarter 2024 Earnings: A Detailed Analysis
Strong Performance with Significant Growth in Net Product Revenue
© 2024 Yahoo. All rights reserved.